Does TELMISARTAN Cause Injection site discolouration? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Injection site discolouration have been filed in association with TELMISARTAN (telmisartan). This represents 0.3% of all adverse event reports for TELMISARTAN.
15
Reports of Injection site discolouration with TELMISARTAN
0.3%
of all TELMISARTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site discolouration From TELMISARTAN?
Of the 15 reports.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which TELMISARTAN Alternatives Have Lower Injection site discolouration Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS